Pharmaceuticals Repackaging Relabeling 2012-2017

The Pharmaceuticals Repackaging Relabeling 2012-2017 Master Indefinite Delivery/Indefinite Quantity (IDIQ) contract was awarded by the Centers for Disease Control and Prevention (CDC) to support pharmaceutical repackaging and relabeling services. The contract vehicle enables the government to procure specialized pharmaceutical transformation services, specifically focusing on converting bulk pharmaceutical materials into standardized, unit-of-use packaging for distribution to healthcare facilities. The primary service involves repackaging, relabeling, and potentially managing inventory for pharmaceutical products across various government healthcare systems.

The contract vehicle consistently awarded task orders to pharmaceutical service providers, with Aphena Pharma Solutions (New Jersey and Tennessee locations) being the most frequent recipient. Task orders typically ranged from approximately $43,000 to $2.4 million, with performance periods generally spanning 12-18 months. Each task order was competitively awarded without specific set-aside designations, indicating open market competition. The contracts were predominantly firm fixed-price delivery orders, supporting pharmaceutical repackaging for agencies like the CDC and Department of Veterans Affairs. Multiple pharmaceutical service companies participated in the contract, including Aphena Pharma Solutions, DSI, and Legacy Pharmaceutical, demonstrating a competitive market for pharmaceutical repackaging and relabeling services.